Neuland Laboratories (NEULANDLAB.NS) Jumps 3.39% to ₹19,970 — CDMO Counter Approaches Key Resistance - Collar Trade
NiveshIQ
NSE: NEULANDLAB · Healthcare
Neuland Laboratories Ltd.
₹19,575.00▼ ₹125.00 (-0.63%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on NEULANDLAB. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Neuland Laboratories Ltd.
Neuland Laboratories Limited, headquartered in Hyderabad, specializes in the manufacture and sale of active pharmaceutical ingredients (APIs) across India, Europe, the United States, and other international markets. The company’s core revenue drivers include the production of generic drug substances, peptide APIs, and custom synthesis services for generic and branded pharmaceutical manufacturers, distributors, and biotechnology firms. In FY27 Q2, Neuland reported a revenue of ₹2,372 crore and a net income of ₹498 crore, reflecting steady profitability amid growing demand for specialty APIs. Recent filings and market coverage indicate a 2.47% share price decline, yet institutional investors such as FIIs and mutual funds have increased stakes, suggesting confidence in long‑term upside. Neula
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,559 Cr +30.84% | ₹1,477 Cr -5.24% | ₹2,023 Cr +36.98% |
| EBITDA Margin | 29.68% | 21.89% | 28.40% |
| Net Profit | ₹300.08 Cr +83.51% | ₹260.11 Cr -13.32% | ₹364.00 Cr +39.94% |
| EPS | ₹233.89 | ₹202.74 | ₹283.71 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Neuland Laboratories (NEULANDLAB.NS) Jumps 3.39% to ₹19,970 — CDMO Counter Approaches Key Resistance - Collar Trade
Neuland Laboratories Q2 FY27 Earnings Call Date and Details
🔒
+ 3 more stories about Neuland Laboratories Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹642 Cr, PAT ₹148 Cr, EPS ₹115.10, EBITDA margin 36.1%. Growth context: revenue QoQ -17.3%, PAT QoQ -30.6%. Street verdict: strong beat, revenue surprise +22.7%, PAT surprise +91.8%.
Test volumes, test mix, B2B/reference‑lab traction, pricing discipline and operating leverage remain the key forward dri...
FY26 (last completed FY): revenue ₹2, 023 Cr, PAT ₹364 Cr, EBITDA margin 29.9%, EPS ₹283.71. Year-on-year: revenue YoY +...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for NEULANDLAB
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track NEULANDLAB alongside your other holdings
Unlock full NEULANDLAB research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Neuland Laboratories Ltd.?
NiveshIQ detects active intelligence signals for Neuland Laboratories Ltd. (NEULANDLAB) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Neuland Laboratories Ltd.?
Neuland Laboratories Ltd. operates in the Healthcare sector with a market capitalisation of ₹2,277,305.2L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.